Physician profile
Michael Seth Smith
NPI 1134377385
$537.32
in general payments reported to CMS, 2019-2025
9 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $27.38 · 2024: $407 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299 · Travel and Lodging: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.67 |
| Travel and Lodging | $238.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $282.65 | 2024 | |
| Ebi, LLC | $62.26 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Si-Bone, INC. | $45.50 | 2023-2024 | |
| Smith+Nephew, INC. | $33.76 | 2024 | Novostitch, Bone Anchors With Arthroscopic Delivery System |
| Amgen INC. | $32.11 | 2024-2025 | Evenity, Prolia, Prolia |
| Endo USA, INC. | $24.80 | 2025 | Xiaflex |
| Spr Therapeutics, INC | $23.07 | 2024 | Sprint Pns System |
| Zimmer Biomet Holdings, INC. | $19.00 | 2024 | Mymobility Platform |
| Depuy Synthes Sales INC. | $14.17 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.